Skip to main content
INSPInspire Medical Systems, Inc.Sell4.6·$62.50-0.90%

Inspire Medical Systems (INSP) Q2 2026 earnings — TrendMatrix coverage

BEAT+157.1% vs estimateEPS $0.14 vs -$0.25 estVerdict Buy (Wait)Hold

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$0.14
Estimate
-$0.25
Surprise
+157.1%
Revenue (period 2026-06-30)
$200.6M
Score at report (before → after)
4.84.8/10

Revenue source: xbrl.

Report record · Q2 2026

How the report landed

Inspire Medical Systems (INSP) beat the -$0.25 estimate with diluted EPS of $0.14 — a large 157.1% upside surprise. TrendMatrix's engine moved from Buy (Wait) (4.8/10) to Hold at 4.8/10 after the report.

Current read · as of 2026-09-04

Where TrendMatrix's rating stands now

TrendMatrix currently rates INSP Sell at 4.6/10.

4 of the last 4 quarters beat the estimate; this quarter's +157.1% surprise compares with a +190.3% four-quarter average. Next scheduled report: 2026-11-02.

What supports the rating

  • Sector modifier (Healthcare): +0.5
  • Strong earnings beat streak (4/4)

What argues against it

  • Concentration risk — Product: Inspire system
  • Earnings expected to decline ~66% (cyclical peak)
  • Analyst target reached - limited upside remaining

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$62.50
Price target
$71.46
Stop
$57.79
Upside to target
+14.3%

Forward estimates sit below the trailing run-rate (40.4× forward vs 13.9× trailing) — consensus expects earnings to decline from here.

Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.

Healthcare context

INSP at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Medical Devices
Market cap
$1.80B
P/E (fwd)
40.4
P/E (ttm)
13.9
52-week range
$38.91$147.03
Off 52-week high
57.5%
RSI (14)
67
Volume vs avg
0.84×
Score today
4.6/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks INSP Earnings Q2 2026 earnings